Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366991911> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4366991911 endingPage "2357" @default.
- W4366991911 startingPage "2351" @default.
- W4366991911 abstract "Background/Aim: Although combination chemotherapy with trifluridine/tipiracil (TAS-102) and bevacizumab (BEV) is highly effective for metastatic unresectable colorectal cancer (mCRC), this combination chemotherapy often induces nausea and vomiting. To identify risk factors for nausea and vomiting, we investigated the occurrence of nausea and vomiting in mCRC patients treated with TAS-102 and BEV. Patients and Methods: Study patients with mCRC received TAS-102 and BEV between March 2016 and December 2021. The status of nausea, vomiting, and antiemetic measures in each course were investigated, and factors involved in the occurrence of nausea and vomiting were analysed by logistic regression analysis. Results: Data from 57 patients were analysed. The incidence rates of nausea and vomiting during the overall period were 57.9% and 17.5%, respectively. Nausea and vomiting were frequent not only in the early courses but also after the sixth course. Multivariate logistic regression analysis showed that the experience of nausea and vomiting in previous treatment with other agents was significantly associated with nausea and vomiting with TAS-102 and BEV. Conclusion: The experience of nausea and vomiting in previous treatment was associated with increased risk for nausea and vomiting in mCRC patients treated with TAS-102 and BEV." @default.
- W4366991911 created "2023-04-27" @default.
- W4366991911 creator A5009158857 @default.
- W4366991911 creator A5018626113 @default.
- W4366991911 creator A5024445851 @default.
- W4366991911 creator A5026657616 @default.
- W4366991911 creator A5029164270 @default.
- W4366991911 creator A5039295775 @default.
- W4366991911 creator A5045525779 @default.
- W4366991911 creator A5046025099 @default.
- W4366991911 creator A5046550344 @default.
- W4366991911 creator A5061553422 @default.
- W4366991911 creator A5061881778 @default.
- W4366991911 creator A5076715179 @default.
- W4366991911 creator A5086245366 @default.
- W4366991911 date "2023-04-25" @default.
- W4366991911 modified "2023-09-27" @default.
- W4366991911 title "Emetogenicity and Risk Factors of Nausea and Vomiting in Patients With Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil and Bevacizumab Chemotherapy" @default.
- W4366991911 doi "https://doi.org/10.21873/anticanres.16400" @default.
- W4366991911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37097664" @default.
- W4366991911 hasPublicationYear "2023" @default.
- W4366991911 type Work @default.
- W4366991911 citedByCount "0" @default.
- W4366991911 crossrefType "journal-article" @default.
- W4366991911 hasAuthorship W4366991911A5009158857 @default.
- W4366991911 hasAuthorship W4366991911A5018626113 @default.
- W4366991911 hasAuthorship W4366991911A5024445851 @default.
- W4366991911 hasAuthorship W4366991911A5026657616 @default.
- W4366991911 hasAuthorship W4366991911A5029164270 @default.
- W4366991911 hasAuthorship W4366991911A5039295775 @default.
- W4366991911 hasAuthorship W4366991911A5045525779 @default.
- W4366991911 hasAuthorship W4366991911A5046025099 @default.
- W4366991911 hasAuthorship W4366991911A5046550344 @default.
- W4366991911 hasAuthorship W4366991911A5061553422 @default.
- W4366991911 hasAuthorship W4366991911A5061881778 @default.
- W4366991911 hasAuthorship W4366991911A5076715179 @default.
- W4366991911 hasAuthorship W4366991911A5086245366 @default.
- W4366991911 hasConcept C121608353 @default.
- W4366991911 hasConcept C126322002 @default.
- W4366991911 hasConcept C2776694085 @default.
- W4366991911 hasConcept C2780580376 @default.
- W4366991911 hasConcept C2780852908 @default.
- W4366991911 hasConcept C2780884295 @default.
- W4366991911 hasConcept C42219234 @default.
- W4366991911 hasConcept C526805850 @default.
- W4366991911 hasConcept C71924100 @default.
- W4366991911 hasConcept C90924648 @default.
- W4366991911 hasConceptScore W4366991911C121608353 @default.
- W4366991911 hasConceptScore W4366991911C126322002 @default.
- W4366991911 hasConceptScore W4366991911C2776694085 @default.
- W4366991911 hasConceptScore W4366991911C2780580376 @default.
- W4366991911 hasConceptScore W4366991911C2780852908 @default.
- W4366991911 hasConceptScore W4366991911C2780884295 @default.
- W4366991911 hasConceptScore W4366991911C42219234 @default.
- W4366991911 hasConceptScore W4366991911C526805850 @default.
- W4366991911 hasConceptScore W4366991911C71924100 @default.
- W4366991911 hasConceptScore W4366991911C90924648 @default.
- W4366991911 hasIssue "5" @default.
- W4366991911 hasLocation W43669919111 @default.
- W4366991911 hasLocation W43669919112 @default.
- W4366991911 hasOpenAccess W4366991911 @default.
- W4366991911 hasPrimaryLocation W43669919111 @default.
- W4366991911 hasRelatedWork W1983173757 @default.
- W4366991911 hasRelatedWork W2020926032 @default.
- W4366991911 hasRelatedWork W2033327063 @default.
- W4366991911 hasRelatedWork W2049464048 @default.
- W4366991911 hasRelatedWork W2079947723 @default.
- W4366991911 hasRelatedWork W2142468847 @default.
- W4366991911 hasRelatedWork W2416851697 @default.
- W4366991911 hasRelatedWork W2549638621 @default.
- W4366991911 hasRelatedWork W2611083795 @default.
- W4366991911 hasRelatedWork W3030615729 @default.
- W4366991911 hasVolume "43" @default.
- W4366991911 isParatext "false" @default.
- W4366991911 isRetracted "false" @default.
- W4366991911 workType "article" @default.